Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide

被引:64
作者
Test, ST [1 ]
Mitsuyoshi, J [1 ]
Connolly, CC [1 ]
Lucas, AH [1 ]
机构
[1] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA
关键词
D O I
10.1128/IAI.69.5.3031-3040.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous studies have demonstrated an adjuvant effect for the C3d fragment of complement C3 when coupled to T dependent protein antigens. In this study. we examined the antibody response to covalent conjugates of C3d and a T-independent antigen, the caps;lar polysaccharide of serotype 14 Streptococcus pneumoniae (PPS14), We prepared a conjugate of mouse C3d and PPS14 and compared its immunogenicity with that of a conjugate of PPS14 and ovalbumin (OVA). When BALB/c mice were immunized, with PPS14-C3d, there was a significant increase in serum anti-PPS14 concentrations compared with either native PPS14 or control PPS14-glycine conjugates, This was accompanied by a switch in anti-PPS14 from predominantly immunoglobulin M (IgM) to IgG1 by day 25 following primary immunization. Following secondary immunization with PPS14-C3d, there was a marked booster response and a further increase in the ratio of IgG1 to IgM anti-PPS14. Although the primary antibody response to the PPS14-OVA conjugate exceeded that induced by immunization with PPS14-C3d, serum anti-PPS14 concentrations after a second injection of PPS14-C3d were nearly identical to those induced blv secondary immunization with PPS14-OVA. Experiments with athymic nude mice suggested that T cells were not required for the adjuvant effect of C3d on the primary immune response to PPS14 but were necessary for enhancement of the memory response after a second injection of PPS14-C3d, These studies show that the adjuvant effects of C3d extend to T-independent antigens as well as T-dependent antigens, As a means of harnessing the adjuvant potential of the innate immune system, C3d conjugates may prole useful as a component of vaccines against encapsulated bacteria.
引用
收藏
页码:3031 / 3040
页数:10
相关论文
共 49 条
[1]  
[Anonymous], 1999, WKLY EPIDEMIOL REC
[2]  
BRALEYMULLEN H, 1975, J IMMUNOL, V115, P1194
[3]  
BROWN EJ, 1985, CURR TOP MICROBIOL, V121, P159
[4]  
Buchanan RM, 1998, J IMMUNOL, V161, P5525
[5]  
CARTER RH, 1988, J IMMUNOL, V141, P457
[6]   C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity [J].
Dempsey, PW ;
Allison, MED ;
Akkaraju, S ;
Goodnow, CC ;
Fearon, DT .
SCIENCE, 1996, 271 (5247) :348-350
[7]  
Dick W E Jr, 1989, Contrib Microbiol Immunol, V10, P48
[8]  
Fang YF, 1998, J IMMUNOL, V160, P5273
[9]   Innate immunity - beginning to fulfill its promise? [J].
Fearon, DT .
NATURE IMMUNOLOGY, 2000, 1 (02) :102-103
[10]  
Fischer MB, 1996, J IMMUNOL, V157, P549